Arrowgrass Capital Partners (US)’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-417
Closed -$802K 298
2014
Q4
$802K Buy
+417
New +$802K 0.01% 180